abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

25 Jun 2014

Author:
African Press Organization

Novartis convenes 13th annual malaria expert panel with a focus on access to quality antimalarials across Africa [25 June, Dar Es Salaam, Tanzania]

See all tags
There is a need for quality-assured antimalarial treatments in both the private and public sectors…Half of patients in Africa buy antimalarials from the private sector…where wide availability of sub-standard treatment is putting patients’ lives at risk… …Malaria experts from countries across Africa are meeting today at the 13th annual National Malaria Control Program (NMCP) Best Practice Sharing Workshop…The gathering provides a platform to discuss and share knowledge and experiences, and to drive dialogue around improved health outcomes and access to quality antimalarial treatments for patients in Africa…Unfortunately, in some countries bednet utilization remains a challenge…while sub-standard antimalarials…and oral artemisinin monotherapies…remain available, primarily through the private sector. These treatments may contain too little or no active ingredient, thereby putting patients’ lives at risk…